Table 1.
Clinicopathological features | Patients (n) |
FOXK2
|
p-value | |
---|---|---|---|---|
Low (n) | High (n) | |||
Sex | 0.974 | |||
Male | 76 | 46 | 30 | |
Female | 75 | 45 | 30 | |
Age | 0.082 | |||
<50 years | 86 | 57 | 29 | |
≥50 years | 65 | 34 | 31 | |
WHO grade | <0.01 | |||
Low (WHO grade I and II) | 57 | 20 | 37 | |
High (WHO grade III and IV) | 94 | 71 | 23 | |
Tumor size | 0.796 | |||
<5 cm | 5 | 30 | 21 | |
≥5 cm | 100 | 61 | 39 | |
Karnofsky Performance Status | 0.152 | |||
<70 | 114 | 65 | 49 | |
≥70 | 37 | 26 | 11 | |
Ki67 | <0.01 | |||
<10% | 68 | 33 | 35 | |
≥10% | 83 | 58 | 25 | |
MGMT | 0.385 | |||
− | 72 | 46 | 26 | |
+ | 79 | 45 | 34 | |
GST-pi | 0.940 | |||
− | 85 | 51 | 34 | |
+ | 66 | 40 | 26 |
Abbreviations: FOXK2, Forkhead box K2; GST-pi, glutathione S-transferase pi; MGMT, O-6-methylguanine-DNA methyltransferase; WHO, World Health Organization.